Breaking News Instant updates and real-time market news.

AVGO

Broadcom

$254.53

19.94 (8.50%)

, LULU

lululemon

$54.29

5.62 (11.55%)

16:13
06/02/17
06/02
16:13
06/02/17
16:13

On The Fly: Top stock stories for Friday

Stocks began the session little changed after the disappointing monthly jobs data but the averages drifted higher throughout the morning. The S&P and Dow settled into a range near noon and mostly moved sideways from there, while the Nasdaq continued to lead and finished the day with nearly a 1% advance. By afternoon the news flow had slowed and the volume became lighter, but the market held its gains into the close with all three major averages finishing the week at all-time closing highs. ECONOMIC EVENTS: In the U.S., the monthly jobs report showed nonfarm payrolls grew by 138,000, versus expectations for the addition of 182,000 jobs. The unemployment rate moved to 4.3% from the prior month's 4.4%. The U.S. trade deficit rose to $47.6B in April from $43.7B in March. In energy news, Baker Hughes reported that the U.S. rig count is up 8 rigs from last week to 916. COMPANY NEWS: Shares of Broadcom Limited (AVGO) advanced 8.5% after the wireless component supplier's better than expected Q2 results... Lululemon's (LULU) shares jumped 11.5% following the "athleisure" retailer's better than expected Q1 results. Another retailer, RH (RH), did not fare as well following its quarterly report, as shares dropped by over 25% after the parent of the Restoration Hardware brand lowered its fiscal year profit guidance... In M&A news, Blackstone (BX) announced that real estate funds managed by the company agrred to sell Logicor to affiliates of China Investment Corporation for EUR12.25B. The transaction is expected to close later this year... Meanwhile, Buffalo Wild Wings (BWLD) shares rose nearly 2% after the company announced that Sally Smith notified the board of her decision to retire as chief executive officer before the end of the year. The Buffalo Wild Wings board has intiated a search process and will engage an executive search firm to help find a successor. In addition, Marcato capital, which owns roughly 9.9% of the outstanding common shares of Buffalo Wild Wings, said that the restaurant chain's shareholders elected Marcato's nominees Scott Bergren, Sam Rovit and Mick McGuire to the restaurant chain operator's board... In addition, Harley-Davidson (HOG) shares were in focus after the National Highway Traffic Administration said that the company was recalling roughly 46,000 motorcycles due to a faulty clamp used to secure an engine oil cooler line. MAJOR MOVERS: Among the notable gainers was Synergy Pharmaceuticals (SGYP), which advanced 10% to $4 per share after Cantor Fitzgerald initiated coverage of the stock with an Overweight rating and an $11 price target. Also higher was Cooper Companies (COO), which gained 8.6% after reporting better than expected quarterly results raising its earnings and revenue guidance for fiscal 2017. Among the noteworthy losers after earnings were Zumiez (ZUMZ) and Hovnanian (HOV), which dropped 12% and 5.5%, respectively. Also lower was Pinnacle Foods (PF), which fell 6.4% after CNBC's David Faber reported that talks regarding a potential acquisition by Conagra (CAG) have come to an end without an agreement being reached. Conagra dipped about 1% lower after the news. INDEXES: The Dow rose 62.11, or 0.29%, to 21,206.29, the Nasdaq gained 58.97, or 0.94%, to 6,305.80, and the S&P 500 advanced 9.01, or 0.37%, to 2,439.07.

AVGO

Broadcom

$254.53

19.94 (8.50%)

LULU

lululemon

$54.29

5.62 (11.55%)

RH

RH

$42.46

-14.79 (-25.83%)

SGYP

Synergy Pharmaceuticals

$4.00

0.37 (10.19%)

COO

Cooper Companies

$238.15

18.36 (8.35%)

ZUMZ

Zumiez

$12.73

-1.725 (-11.94%)

HOV

Hovnanian

$2.35

-0.16 (-6.37%)

PF

Pinnacle Foods

$61.94

-3.945 (-5.99%)

CAG

Conagra Brands

$39.57

-0.38 (-0.95%)

HOG

Harley-Davidson

$53.23

-0.08 (-0.15%)

BX

Blackstone

$33.68

0.23 (0.69%)

BWLD

Buffalo Wild Wings

$152.35

2.6 (1.74%)

  • 02

    Jun

  • 06

    Jun

  • 13

    Jun

  • 02

    Oct

AVGO Broadcom
$254.53

19.94 (8.50%)

06/02/17
RHCO
06/02/17
NO CHANGE
RHCO
Broadcom should be bought at current levels, says SunTrust
SunTrust analyst William Stein recommends buying Broadcom's stock after the company reported beat and raise results. The analyst thinks that the company's free cash flow will enable it to make another major acquisition "when the time is right." He raised his price target on the shares to $274 from $252.
06/02/17
UBSW
06/02/17
NO CHANGE
Target $265
UBSW
Buy
Broadcom price target raised to $265 from $245 at UBS
UBS analyst Stephen Chin raised his price target on Broadcom (AVGO) to $265 from $245 following its beat and raise Q2 report. The analyst sees upside in its wireline business and content wins from Apple (AAPL) over the next few quarters. He noted the company raised guidance accordingly. Chin reiterated his Buy rating and said the current multiple remains attractive on Broadcom shares.
06/02/17
DBAB
06/02/17
NO CHANGE
Target $275
DBAB
Buy
Broadcom price target raised to $275 from $255 at Deutsche Bank
Deutsche Bank analyst Ross Seymore raised his price target for Broadcom to $275 saying "consistent strength in business and strategy continues" following the company's better than expected Q2 results. Management reiterated their commitment to a disciplined M&A strategy and increased cash returns, which will likely calm fears following recent Toshiba related press reports, Seymore tells investors in a post-earnings research note. He reiterates a Buy rating on Broadcom.
06/02/17
LOOP
06/02/17
NO CHANGE
Target $285
LOOP
Buy
Loop Capital surprised by Broadcom 'candid disclosure' about iPhone content
Loop Capital analyst Betsy Van Hees noted that Broadcom's (AVGO) Q2 results beat her Street high estimates, adding that she was "positively surprised" by the company's "candid disclosure" that its content in Apple's (AAPL) iPhone 8 is increasing by 40% from the 7. The analyst, who calls Broadcom one of her top big cap picks for 2017, raised her price target on the shares to $285 from $270 and maintains a Buy rating.
LULU lululemon
$54.29

5.62 (11.55%)

06/02/17
STFL
06/02/17
NO CHANGE
STFL
lululemon results 'challenge concerns,' says Stifel
Stifel analyst Jim Duffy says that lululemon's "double digit e-commerce growth and positive comp sales challenge widespread concerns about (its) category and brand relevance." The analyst is now more confident that the comapny's comparable sales will accelerate in 2H17 and more upbeat about its ability to meet fiscal 2017 estimates. He keeps a $60 price target on the shares, but he thinks that his target can increase later in the eyar. Duffy keeps a Buy rating on the stock.
06/02/17
ADAM
06/02/17
NO CHANGE
Target $41
ADAM
Sell
lululemon fundamentals remain soft, says Canaccord
Canaccord analyst Camilo Lyon noted lululemon's Q1 results beat expectations but they belie the deceleration across a number of categories. Lyon's bear thesis is unchanged as he continues to see downside from headwinds including competitive pressures and a fashion shift toward denim. Lyon said the absolute fundamentals remains soft and do not warrant a premium multiple. Lyon reiterated his Sell rating and $41 price target on lululemon shares.
06/02/17
LEHM
06/02/17
NO CHANGE
Target $85
LEHM
Overweight
Barclays believes worst is now behind lululemon
In a post-earnings research note titled "Bras are the New Women's Bottoms," Barclays analyst Matthew McClintock says he believes the worst is now behind lululemon. Despite "significant" operational miscues, the company posted a quarter "that most retailers in today's environment would love to have," McClintock writes. He expects lululemon's numerous initiatives, including its first global marketing campaign, improved color assortment and "dominant response" to the Enlite bra offering, to deliver accelerating growth. The analyst keeps an Overweight rating on lululemon with an $85 price target. The stock jumped 16% to $56.50 last night in after-hours trading.
06/02/17
OPCO
06/02/17
NO CHANGE
Target $65
OPCO
Outperform
Opco says put new money to work in lululemon despite rally
Oppenheimer analyst Anna Andreeva recommends putting new money to work in lululemon despite the stock's 16% post-earnings rally. Even when the company a product misstep, "powerful brand equity brings the consumer back quickly," Andreeva tells investors in a research note following the retailer's Q1 results. She reiterates an Outperform rating on the shares with a $65 price target, noting that she'd chase the shares at current levels.
RH RH
$42.46

-14.79 (-25.83%)

06/02/17
DBAB
06/02/17
NO CHANGE
Target $45
DBAB
Hold
RH price target lowered to $45 from $50 at Deutsche Bank
Deutsche Bank analyst Adam Sindler lowered his price target for RH to $45 after the company issued Q2 and FY17 outlooks below consensus. Further SKU rationalization remains the key downside risk, Sindler tells investors in a post-earnings research note. On the other side, the analyst believes RH "could dip into" its new $700M buyback authorization "sooner rather than later." The analyst sees potential for further estimate cuts and keeps a Hold rating on the shares.
06/02/17
BOFA
06/02/17
NO CHANGE
Target $64
BOFA
Buy
RH continued SKU optimization drives lower 2017 guidance, says BofA/Merrill
BofA/Merrill analyst Lorraine Hutchinson said RH's continued inventory optimization will increase sales and free cash flow but will limit and earnings rebound in 2017, resulting in lower 2017 earnings guidance. The analyst thinks most of the company-specific issues are behind the company and the real estate transformation and Modern remain compelling growth opportunities. Hutchinson maintains a Buy rating and $64 price target on RH shares.
06/02/17
KEYB
06/02/17
NO CHANGE
KEYB
RH outlook still positive, says KeyBanc
After RH provided Q2 EPS guidance that KeyBanc analyst Bradley Thomas finds "disappointing," he is "encouraged" by the company's comp sales, inventory reductions, the outlook for its new stores, and its potential for share repurchases. The analyst remains upbeat on the company's longer term outlook and keeps an Overweight rating on the shares.
06/02/17
SBSH
06/02/17
NO CHANGE
SBSH
Buy
RH post-earnings selloff a buying opportunity, says Citi
Citi analyst Geoffrey Small recommends using the post-earnings selloff in shares of RH as a buying opportunity. The stock in premarket trading is down 20% to $45.70. The analyst views the quarter's underlying sales as strong and notes that share buybacks could drive upside to guidance.
SGYP Synergy Pharmaceuticals
$4.00

0.37 (10.19%)

03/21/17
BTIG
03/21/17
NO CHANGE
Target $11
BTIG
Buy
Synergy Pharmaceuticals weakness a buying opportunity, says BTIG
BTIG analyst Timothy Chiang said weakness in Synergy Pharmaceuticals is a buying opportunity. The analyst said investor focus is now on the ramp for Trulance in the US market and he believes management is up to the task of successfully launching Trulance via its hybrid sales model which is expected to target approximately 27,000 high-prescribing physicians. Chiang rates Synergy a Buy with an $11 price target.
04/06/17
SBSH
04/06/17
DOWNGRADE
Target $3.7
SBSH
Sell
Synergy Pharmaceuticals downgraded to Sell from Neutral at Citi
Citi analyst Liav Abraham downgraded Synergy Pharmaceuticals to Sell saying she sees downside over the next two years to both sales and operating income consensus estimates. The analyst believes the Trulance launch is likely to disappoint and that a takeover appears unlikely. Abraham cut her price target for Synergy shares to $3.70 from $6.50 after removing any takeover premium.
06/01/17
CANT
06/01/17
INITIATION
Target $11
CANT
Overweight
Synergy Pharmaceuticals initiated with an Overweight at Cantor
Cantor initiated Synergy Pharmaceuticals with an Overweight and an $11 price target.
06/02/17
06/02/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Synergy Pharmaceuticals (SGYP) initiated with an Overweight at Cantor. 2. Fastenal (FAST) was initiated with an Overweight at Stephens and a Neutral at JPMorgan. 3. Ericsson (ERIC) was reinstated with a Buy at BofA/Merrill while Nokia (NOK) was reinstated with a Neutral. 4. John Bean Technologies (JBT) initiated with a Neutral at JPMorgan. 5. Biocept (BIOC) initiated with a Buy at Chardan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
COO Cooper Companies
$238.15

18.36 (8.35%)

06/02/17
BMOC
06/02/17
NO CHANGE
BMOC
Cooper Companies reported 'very good' results, says BMO Capital
BMO Capital analyst JoanneWuensch says that Cooper reported "very good" Q2 results. Wuensch thinks that the company's gross margins were "impressive," She raised her price target on the stock to $255 from $220 and keeps an Outperform rating on the shares.
01/19/17
PIPR
01/19/17
NO CHANGE
PIPR
Cooper acquisition less likely after Essilor-Luxottica merger, says Piper
Piper Jaffray analyst Matt O'Brien believes Cooper Companies is less likely to be acquired by Essilor, as it will be focused on merging with Luxottica. However, O'Brien maintains an Overweight rating as he believes Cooper's fundamentals are "quite strong."
06/02/17
PIPR
06/02/17
NO CHANGE
Target $235
PIPR
Overweight
Cooper Companies price target raised to $235 from $220 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien says there is lots to like in Cooper Companies' franchise following the "strong" Q2 results and raised 2017 outlook. He continues to recommend investors own the name and upped his price target for the shares to $235. The analyst keeps an Overweight rating on Cooper.
06/02/17
JEFF
06/02/17
NO CHANGE
Target $250
JEFF
Buy
Cooper Companies price target raised to $250 from $220 at Jefferies
Jefferies analyst Anthony Petrone raised his price target for Cooper Companies to $250 citing the earnings beat and raised FY18 guidance. The analyst sees room for further earnings upside and keeps a Buy rating on the shares.
ZUMZ Zumiez
$12.73

-1.725 (-11.94%)

12/22/16
RILY
12/22/16
DOWNGRADE
RILY
Neutral
Zumiez downgraded to Neutral from Buy at B. Riley
10/13/16
PIPR
10/13/16
UPGRADE
Target $44
PIPR
Overweight
Under Armour upgraded to Overweight after teen survey at Piper Jaffray
As previously reported, Piper Jaffray analyst Erinn Murphy upgraded Under Armour (UA) to Overweight from Neutral following the firm's semi-annual proprietary "Taking Stock With Teens" survey. The survey findings support on-going traction for Under Armour within footwear and the women's segment, noted Murphy, who raised her price target on the stock to $44 from $40. Based on the survey's results, other analysts at the firm also downgraded Estee Lauder (EL) to Neutral from Overweight and upgraded Zumiez (ZUMZ) to Overweight from Neutral.
11/04/16
WOLF
11/04/16
UPGRADE
WOLF
Peer Perform
Zumiez upgraded to Peer Perform from Underperform at Wolfe Research
Wolfe Research upgraded Zumiez to Peer Perform as comps have turned positive, promotions are down, and inventory reduced.
12/22/16
RILY
12/22/16
DOWNGRADE
Target $25
RILY
Neutral
Zumiez downgraded to Neutral from Buy at B. Riley
B. Riley analyst Jeff Van Sinderen downgraded Zumiez to Neutral and lowered his price target for the shares to $25 from $27. The analyst cites his reduced EBITDA multiple for the downgrade.
HOV Hovnanian
$2.35

-0.16 (-6.37%)

01/12/17
JMPS
01/12/17
DOWNGRADE
JMPS
Underperform
Hovnanian downgraded to Underperform from Market Perform at JMP Securities
01/12/17
JMPS
01/12/17
DOWNGRADE
JMPS
Underperform
Hovnanian downgraded on valuation, tough comps at JMP Securities
As noted earlier, JMP Securities downgraded Hovnanian to Underperform from Market Perform. As reasons for the downgrade, analyst Peter Martin cited valuation and "extremely difficult community count comps" in 1H17. Target $1.60.
PF Pinnacle Foods
$61.94

-3.945 (-5.99%)

06/01/17
SPHN
06/01/17
NO CHANGE
Target $63
SPHN
Overweight
Pinnacle Foods acquisition price could be in $75-$80 range, says Stephens
Stephens analyst Farha Asiam commented on news reports that Conagra Brands (CAG) has approached Pinnacle Foods (PF) about a potential acquisition. The analyst estimates an acquisition price could be in the $75-$80 per share range and would be a compelling acquisition target for Conagra given a complimentary portfolio of frozen food brands and synergies. Asiam rates Pinnacle an Overweight with a $63 price target.
06/01/17
FBCO
06/01/17
NO CHANGE
FBCO
Neutral
Conagra would be wise to 'pay up' for Pinnacle, says Credit Suisse
After Reuters reported that Conagra Brands (CAG) approached Pinnacle Foods (PF) regarding a potential acquisition, Credit Suisse analyst Robert Moskow called Pinnacle a "uniquely attractive opportunity" for Conagra and contends that paying a "hefty premium" to complete a deal probably represents Conagra's best option. Moskow, who thinks Conagra needs to do something "more aggressive" to improve its portfolio longer-term, keeps a Neutral rating on Conagra shares.
06/01/17
JPMS
06/01/17
NO CHANGE
JPMS
JPMorgan positive on potential Conagra acquisition of Pinnacle
After Reuters reported Conagra Brands (CAG) recently approached Pinnacle Foods (PF) to express interest in an acquisition, JPMorgan analyst Ken Goldman says a combination "makes a great deal of strategic sense." A deal would be accretive to Conagra's earnings, though perhaps not as much as some observers believe, Goldman tells investors in a research note. The analyst models 13% earnings accretion to Conagra from the deal, including all costs and synergies.
05/16/17
BREN
05/16/17
INITIATION
Target $68
BREN
Buy
Pinnacle Foods initiated with a Buy at Berenberg
Berenberg analyst Adam Mizrahi initiated Pinnacle Foods with a Buy and a $68 price target given a high degree of cost savings visibility that will be a driver of 360bps of gross margin expansion over the next three years. The analyst also said Pinnacle has an attractive product portfolio and expects the company to increase its focus on consolidation this year and build on its track record of accretive acquisitions, but also notes its a possibility that Pinnacle is acquired.
CAG Conagra Brands
$39.57

-0.38 (-0.95%)

04/25/17
04/25/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Amazon.com (AMZN) downgraded to Market Perform from Outperform at Raymond James with analyst Aaron Kessler saying the shares are fairly valued after rallying 21% this year and 44% over the last 12 months. The analyst expects Amazon's investment levels to remain elevated in the near-term and he views consensus operating income estimates for the second quarter as aggressive. 2. General Electric (GE) downgraded to Neutral from Buy at BofA/Merrill with analyst Andrew Obin saying he sees headwinds from weaker Oil & Gas margin, Healthcare, and Power and reduced estimates below consensus. 3. Conagra Brands (CAG) downgraded to Sell from Neutral at UBS with analyst Steven Strycula citing expectations the stock's relative valuation premium will contract amid a decelerating rate of margin improvement and "limited room" for positive earnings estimate revisions. Conagra's portfolio is not well positioned for a consolidating merchandise set, the analyst contends. He cut his price target for the shares to $35 from $38. 4. NGL Energy Partners (NGL) downgraded to Market Perform from Outperform at FBR Capital with analyst Robert Balsamo saying the company's guidance reflects underappreciated risks to its cash flows. 5. Akorn (AKRX) was downgraded to Hold from Buy at Jefferies and Craig-Hallum, to Market Perform from Outperform at William Blair, and to Neutral from Overweight at Piper Jaffray. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HOG Harley-Davidson
$53.23

-0.08 (-0.15%)

05/23/17
TIGR
05/23/17
NO CHANGE
TIGR
Buy
Harley-Davidson recent weakness a buying opportunity, says Tigress Financial
Tigress Financial analyst Ivan Feinseth said he views the recent weakness in Harley-Davidson shares as a buying opportunity, as he believes the company's financial position continues to improve and that Harley can grow ridership as it continues to dominate the heavy cycle market and its EagleRider alliance can extend its outreach. He keeps a Buy rating on Harley shares.
05/18/17
NRCS
05/18/17
NO CHANGE
NRCS
Neutral
Harley-Davidson checks indicate trends deteriorated in April, says Northcoast
Northcoast analyst Seth Woolf said recent checks indicate Harley-Davidson retail trends deteriorated in April despite a meaningfully easing in comps. The analyst is hearing chatter that MY17 models have started to be discounted, earlier than they did last year, and does not given him confidence in MKE-8 acceleration. The analyst is maintaining his US retail estimate of down 1.2% for now but as he believes sales are running close to that level and said there could be modest downside to his down 1.8% global estimate and 85k unit shipment forecast if trends to not improve. Woolf rates Harley-Davidson a Neutral.
05/25/17
BMOC
05/25/17
NO CHANGE
BMOC
Harley-Davidson should be bought on weakness, says BMO Capital
BMO Capital analyst Gerrick Johnson cut his Q2 retail sales growth estimate for Harley-Davidson to 2% from 5%, citing wetter than usual weather. However, the analyst says that "dealer outlooks are improving," while the company is gaining market share and its "innovation remains strong." He recommends buying the stock on weakness.
04/20/17
BERN
04/20/17
NO CHANGE
BERN
Harley-Davidson shipping guidance now 'somewhat ambitious,' says Bernstein
Bernstein analyst David Beckel says that the 6% decline in Harley-Davidson's U.S. retail sales makes the company's guidance for flat to slightly down shipments in fiscal 2017 "somewhat ambitious." The analyst cut his price target on the shares to $62 from $68 but keeps an Outperform rating on the stock.
BX Blackstone
$33.68

0.23 (0.69%)

05/22/17
SBSH
05/22/17
UPGRADE
Target $40
SBSH
Buy
Blackstone upgraded to Buy from Neutral at Citi
Citi analyst William Katz upgraded Blackstone Group to Buy and raised his price target for the shares to $40 from $32. The company's intentions to raise a $40B infrastructure fund should be a "valuation catalyst," the analyst contends.
05/22/17
05/22/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Neutral at JPMorgan with analyst Rod Hall saying while more negative news from the Apple (AAPL) royalty suit is likely, "material fundamental upside" exists from the closure of the NXP Semiconductors (NXPI) by the end of this year. The analyst views the deal as highly accretive. Hall also believes Apple ultimately will want to preserve its commercial relationship with Qualcomm. 2. Motorola Solutions (MSI) upgraded to Outperform from Market Perform at Raymond James with analyst Tavis McCourt saying shares look increasingly attractive based on improved demand visibility that is less economically sensitive than many of its peers, and demand catalysts from FirstNet buildouts that are expected to start in 2018. 3. Entegris (ENTG) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Toshiya Hari citing the recent pullback in shares and maintained a $29 price target. 4. Blackstone (BX) upgraded to Buy from Neutral at Citi with analyst William Katz saying the company's intentions to raise a $40B infrastructure fund should be a "valuation catalyst." 5. Cree (CREE) upgraded to Outperform from Market Perform at JMP Securities with analyst Joseph Osha saying he thinks that the company's new CEO could make positive changes at the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/22/17
JMPS
05/22/17
NO CHANGE
JMPS
Blackstone deal with Saudi Arabia positive, says JMP Securities
JMP Securities analyst Devin Ryan says that the new infrastructure investment vehicle that Blackstone launched with the Public Investment Fund of Saudi Arabia may boost the shareholder value of Blackstone by over 10%. The analyst adds that the deal shows that Blackstone "can evolve and innovate," which makes its growth outlook "strong." He keeps a $38 price target and Outperform rating on the shares.
04/10/17
MSCO
04/10/17
NO CHANGE
Target $36
MSCO
Overweight
Morgan Stanley says to own Blackstone into the Q1 print
Morgan Stanley analyst Michael Cyprys says to buy Blackstone into the Q1 print saying its a best-in-class franchise which saw a number of large transactions close and has unparalleled fundraising ability. Cyprys rates Blackstone an Overweight with a $36 price target.
BWLD Buffalo Wild Wings
$152.35

2.6 (1.74%)

05/30/17
WEDB
05/30/17
DOWNGRADE
Target $115
WEDB
Underperform
Wedbush calls proxy vote irrelevant, cuts Buffalo Wild Wings to sell
Wedbush analyst Nick Setyan downgraded Buffalo Wild Wings to Underperform from Neutral and lowered his price target for the shares to $115 from $150. The restaurant chain closed Friday down $2.25 to $151.00. The upcoming proxy vote is irrelevant as neither management's strategy nor Marcato Capital's plan offer a viable solution to the company's ongoing deterioration in fundamentals, Setyan tells investors in a research note. Underperform is Wedbush's equivalent to a sell rating.
05/30/17
05/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ambarella (AMBA) downgraded to Sector Weight from Overweight at Pacific Crest with analyst Brad Erickson citing concern the company's largest customer DJI may have dual-sourced. After speaking with DJI customer service, Erickson believes Ambarella may not be the video processing provider for Spark, the $499 drone launched last week by DJI. 2. Buffalo Wild Wings (BWLD) downgraded to Underperform from Neutral at Wedbush with analyst Nick Setyan saying the upcoming proxy vote is irrelevant as neither management's strategy nor Marcato Capital's plan offer a viable solution to the company's ongoing deterioration in fundamentals. 3. Valero (VLO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Benny Wong citing refining headwinds and high exposure to RIN prices. 4. AutoZone (AZO) and O'Reilly Automotive (ORLY) were downgraded to Neutral from Outperform at Wedbush. 5. Whiting Petroleum (WLL) was downgraded to Sell from Neutral at Goldman Sachs, while Cimarex Energy (XEC) and Hess Corp. (HES) were downgraded to Neutral from Buy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/02/17
DBAB
06/02/17
NO CHANGE
Target $180
DBAB
Buy
Buffalo Wild Wings can refocus with board fight settled, says Deutsche Bank
After Buffalo Wild Wings CEO Sally Smith announced that she would be retiring from the company by year end or sooner and investors elected three of Marcato's four nominees to the company's board, Deutsche Bank analyst Brett Levy said he believes management can now re-focus on improving fundamentals and cutting costs. The changes also create a greater likelihood the company will accelerate its pace of change and explore other initiatives, added Levy, who keeps a Buy rating and $180 price target on the stock.
05/30/17
WEDB
05/30/17
DOWNGRADE
Target $115
WEDB
Underperform
Buffalo Wild Wings downgraded to Underperform from Neutral at Wedbush

TODAY'S FREE FLY STORIES

MSBI

Midland States

$33.03

-0.07 (-0.21%)

19:02
10/16/17
10/16
19:02
10/16/17
19:02
Hot Stocks
Midland States to acquire Alpine Bancorporation in roughly $181M deal »

Midland States Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 15

    Nov

MYL

Mylan

$38.18

0.23 (0.61%)

, AGN

Allergan

$198.41

-7.11 (-3.46%)

18:46
10/16/17
10/16
18:46
10/16/17
18:46
Hot Stocks
Mylan CEO: 'Pleased' with court ruling on Allergan's Restasis patents »

Mylan (MYL) announced…

MYL

Mylan

$38.18

0.23 (0.61%)

AGN

Allergan

$198.41

-7.11 (-3.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

  • 03

    Dec

NFLX

Netflix

$202.68

3.19 (1.60%)

18:44
10/16/17
10/16
18:44
10/16/17
18:44
Hot Stocks
Netflix says seeing steady growth, great success for streaming »

Says still has bias…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 22

    Oct

PCG

PG&E

$53.43

-4.29 (-7.43%)

18:42
10/16/17
10/16
18:42
10/16/17
18:42
Hot Stocks
PG&E sees restoring service to all electric customers in CA affected by fires »

PG&E said that more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 05

    Nov

  • 05

    Nov

CYTR

CytRx

$0.38

-0.0142 (-3.64%)

18:29
10/16/17
10/16
18:29
10/16/17
18:29
Hot Stocks
CytRx granted listing extension pending results of stockholder vote »

CytRx 's request for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

EADSY

Airbus

$22.75

-0.07 (-0.31%)

, BDRBF

Bombardier

$1.88

0.03 (1.62%)

18:27
10/16/17
10/16
18:27
10/16/17
18:27
Hot Stocks
Airbus and Bombardier announce C Series partnership »

Airbus (EADSY) and…

EADSY

Airbus

$22.75

-0.07 (-0.31%)

BDRBF

Bombardier

$1.88

0.03 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMDZ

Immune Design

$10.10

-0.85 (-7.76%)

18:16
10/16/17
10/16
18:16
10/16/17
18:16
Conference/Events
Immune Design to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 08

    Nov

PG

Procter & Gamble

$93.14

0.1 (0.11%)

18:15
10/16/17
10/16
18:15
10/16/17
18:15
Hot Stocks
Trian: P&G board election results 'too close to call' »

Trian Fund Management,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

AMZN

Amazon.com

$1,006.34

3.4 (0.34%)

18:14
10/16/17
10/16
18:14
10/16/17
18:14
Periodicals
NJ leaders offer up to $7B in tax incentives to lure Amazon to Newark, WSJ says »

New Jersey Governor Chris…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 22

    Oct

  • 26

    Oct

BDRBF

Bombardier

$1.88

0.03 (1.62%)

, EADSY

Airbus

$22.75

-0.07 (-0.31%)

18:09
10/16/17
10/16
18:09
10/16/17
18:09
Periodicals
Bombardier in talks with Airbus over CSeries jet unit JV, WSJ reports »

Bombardier (BDRBF) is in…

BDRBF

Bombardier

$1.88

0.03 (1.62%)

EADSY

Airbus

$22.75

-0.07 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPXL

Impax

$19.95

-0.85 (-4.09%)

17:55
10/16/17
10/16
17:55
10/16/17
17:55
Hot Stocks
Impax jumps 6% in after-hours after WSJ says Amneal deal near »

Shares of Impax are up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

IPXL

Impax

$19.95

-0.85 (-4.09%)

17:51
10/16/17
10/16
17:51
10/16/17
17:51
Periodicals
Impax and Amneal close to merger pact, WSJ says »

Impax Laboratories and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

AGII

Argo Group

$62.90

-0.25 (-0.40%)

17:36
10/16/17
10/16
17:36
10/16/17
17:36
Hot Stocks
Argo Group provides preliminary Q3 loss estimate »

Argo Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDEF

First Defiance Financial

$53.65

-0.25 (-0.46%)

17:34
10/16/17
10/16
17:34
10/16/17
17:34
Earnings
First Defiance Financial reports Q3 EPS 92c, consensus 89c »

Reports Q3 NII $ $25.0M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

BRO

Brown & Brown

$48.97

-0.42 (-0.85%)

17:33
10/16/17
10/16
17:33
10/16/17
17:33
Earnings
Brown & Brown reports Q3 EPS 53c, consensus 50c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ORIG

Ocean Rig UDW

$26.18

0.51 (1.99%)

17:31
10/16/17
10/16
17:31
10/16/17
17:31
Hot Stocks
Ocean Rig holder BlueMountain intends to recommend company hire advisers »

Ocean Rig UDW holder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$202.68

3.19 (1.60%)

, IMDZ

Immune Design

$10.10

-0.85 (-7.76%)

17:31
10/16/17
10/16
17:31
10/16/17
17:31
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

NFLX

Netflix

$202.68

3.19 (1.60%)

IMDZ

Immune Design

$10.10

-0.85 (-7.76%)

SAVE

Spirit Airlines

$33.47

-0.33 (-0.98%)

UNH

UnitedHealth

$193.20

0.68 (0.35%)

BMI

Badger Meter

$50.80

-0.6 (-1.17%)

SONC

Sonic

$24.80

0.42 (1.72%)

ABEO

Abeona Therapeutics

$16.70

0.6 (3.73%)

VICL

Vical

$2.86

0.04 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

  • 23

    Oct

  • 08

    Nov

  • 17

    Oct

FDC

First Data

$18.01

0.39 (2.21%)

17:28
10/16/17
10/16
17:28
10/16/17
17:28
Hot Stocks
First Data CAO sells 3,996 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 30

    Oct

ROSG

Rosetta Genomics

$1.00

-0.0479 (-4.57%)

17:28
10/16/17
10/16
17:28
10/16/17
17:28
Syndicate
Breaking Syndicate news story on Rosetta Genomics »

Rosetta Genomics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRS

Harris

$135.90

-0.66 (-0.48%)

17:27
10/16/17
10/16
17:27
10/16/17
17:27
Hot Stocks
Harris awarded $100M government contract modification »

Harris Corp., Clifton,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$259.75

-0.99 (-0.38%)

17:26
10/16/17
10/16
17:26
10/16/17
17:26
Hot Stocks
Boeing awarded $240.2M government contract »

The Boeing Co., Oklahoma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PI

Impinj

$34.98

-0.71 (-1.99%)

17:22
10/16/17
10/16
17:22
10/16/17
17:22
Hot Stocks
Impinj COO sells 7,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 14

    Nov

  • 15

    Nov

ADOM

Adomani

$6.50

-0.36 (-5.25%)

17:21
10/16/17
10/16
17:21
10/16/17
17:21
Syndicate
Breaking Syndicate news story on Adomani »

Adomani files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAVE

Spirit Airlines

$33.47

-0.33 (-0.98%)

17:20
10/16/17
10/16
17:20
10/16/17
17:20
Hot Stocks
Spirit Airlines raises Q3 total RASM view to (6.5%) from (8.5%)-(7%) »

Sees Q3 ASMs up 18%. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RESN

Resonant

$4.38

-0.08 (-1.79%)

17:16
10/16/17
10/16
17:16
10/16/17
17:16
Hot Stocks
Breaking Hot Stocks news story on Resonant »

Longboard raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.